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SUMMARY
Whether cell forces or extracellular matrix (ECM) can impact genome integrity is largely unclear. Here, acute perturbations (1 h) to actomyosin stress or ECM elasticity cause rapid and reversible changes in lamin-A, DNA damage, and cell cycle. The findings are especially relevant to organs such as the heart because DNA damage permanently arrests cardiomyocyte proliferation shortly after birth and thereby eliminates regeneration after injury including heart attack. Embryonic hearts, cardiac-differentiated iPS cells (induced pluripotent stem cells), and various nonmuscle cell types all show that actomyosindriven nuclear rupture causes cytoplasmic mis-localization of DNA repair factors and excess DNA damage. Binucleation and micronuclei increase as telomeres shorten, which all favor cell-cycle arrest. Deficiencies in lamin-A and repair factors exacerbate these effects, but lamin-A-associated defects are rescued by repair factor overexpression and also by contractility modulators in clinical trials. Contractile cells on stiff ECM normally exhibit low phosphorylation and slow degradation of lamin-A by matrixmetalloprotease-2 (MMP2), and inhibition of this lamin-A turnover and also actomyosin contractility are seen to minimize DNA damage. Lamin-A is thus stress stabilized to mechano-protect the genome.
INTRODUCTION
Proliferation of many cell types slows dramatically shortly after birth and is absent in key adult tissues (Li et al., 1996) , which presents a major challenge to regeneration. Cell growth in culture is modulated by the stiffness of the extracellular matrix (ECM), which generally promotes actomyosin stress (Engler et al., 2006; Paszek et al., 2005) and affects the conformation (Sawada et al., 2006) , post-translational modification (PTM) (Guilluy et al., 2014) , localization (Dupont et al., 2011) , and degradation of mechanosensitive proteins. Actomyosin links to ECM and to nuclei, such that rapid changes to the ECM and tissue mechanics that result from chronic or acute injury or even drug therapies (e.g., cardiac arrest or cardiomyopathy treatment [Green et al., 2016] ) can in principle affect the nucleus (Takaki et al., 2017; Wiggan et al., 2017; Kanellos et al., 2015) and perhaps the DNA within. DNA damage and telomere shortening are indeed well documented in injuries that affect the heart (Chang et al., 2018; Sharifi-Sanjani et al., 2017; Oh et al., 2003) , as well as nonmuscle tissue-but DNA damage and repair are rarely studied in developing organs, and relationships to proliferation, ECM stiffness, and actomyosin stress are understudied.
DNA damage and senescence increase with many diseaselinked mutations, including those in the nucleoskeletal protein lamin-A (LMNA) that forms a structural meshwork around chromatin (Turgay et al., 2017; Shimi et al., 2015; Gruenbaum et al., 2005) . LMNA deficiencies associate with elevated DNA damage (Graziano et al., 2018; Liu et al., 2005) and result in accelerated aging of stiff tissues similar to deficiencies in DNA repair factors (e.g., KU80) (Li et al., 2007) . Moreover, progeroid syndromes are caused only by mutations in LMNA and multiple DNA repair factors, but LMNA's primary function in development remains hotly debated (Burke and Stewart, 2013) , with supposed roles in gene positioning and regulation (Harr et al., 2015) seeming at odds with largely normal development of human and mouse mutants until weeks after birth. Surprisingly, senescence or apoptosis of cells with LMNA defects is rescued by culturing cells on almost any ECM (versus rigid plastic [de La Rosa et al., 2013; Hernandez et al., 2010] ) and by treatment with at least one drug affecting both cytoskeleton and nucleo-cytoplasmic trafficking (Larrieu et al., 2018 (Larrieu et al., , 2014 . Relationships between lamins, (legend continued on next page) actomyosin stress, ECM mechanics, and DNA damage are nonetheless obscure-especially in tissues.
Embryonic hearts beat spontaneously for days after isolation from early chick embryos, and beating is acutely sensitive to myosin-II inhibition ( Figure 1A ), as well as enzymatic stiffening or softening of the ECM (Majkut et al., 2013) . The latter studies reveal an optimal stiffness for beating that is likewise evident for cardiomyocytes (CMs) cultured on gels (Majkut et al., 2013; Engler et al., 2008; Jacot et al., 2008) . DNA damage is conceivably optimized in heart as it triggers a switch from proliferation to senescence in post-natal hearts (Puente et al., 2014) . DNA damage is also implicated in telomere attrition and binucleation of CMs that signal irreversible exit from cell cycle (Aix et al., 2016) . We postulated embryonic hearts with rapidly tunable mechanics could prove useful as a tissue model for clarifying protein-level mechanosensing mechanisms in vivo that could be studied thoroughly in vitro with many cell types.
LMNA is reportedly ''undetectable'' in early embryos (Stewart and Burke, 1987) , but it accumulates clearly and progressively in tissues such as heart, bone, and lung (Solovei et al., 2013; Rö ber et al., 1989; Lehner et al., 1987) and is highest in adults within these mechanically stressed, stiff tissues that are collagen rich . LMNA deficiencies accordingly produce measurable defects weeks after birth in such tissues, including heart (Kubben et al., 2011; Worman and Bonne, 2007) . We therefore hypothesized that LMNA in normal embryos mechanosenses the earliest microenvironment in the first organ and increases not only to stiffen the nucleus (Osmanagic-Myers et al., 2015; Dahl et al., 2008; Pajerowski et al., 2007) but also to regulate repair factors that confer resistance to both DNA damage and cell-cycle arrest.
RESULTS

Contractility and Collagen Perturbations Rapidly Impact LMNA and DNA Damage in Hearts
To first assess the consequences of cytoskeletal stress on nuclei in a tissue, we arrested embryonic hearts (embryonic day [E] 4) with reversible inhibitors of myosin-II ( Figure 1A ). Spontaneous beating of hearts stopped in minutes with blebbistatin (blebb), but the heart re-started just as quickly upon washout of drug ( Figure 1A , right). An activator of cardiac myosin-II omecamtiv mecarbil (''OM'')-in clinical trials for heart failure (National Institutes of Health, 2016b [NCT02929329])-re-started the hearts reliably. Quantitative immunoblots and mass spectrometry (MS) measurements ( Figures 1B, 1C -i, S1A, and S1B) revealed a rapid decrease in LMNA (45 min decay constant), while LMNB remained unchanged ( Figure 1C -i, upper right inset; Figure 1C) , and similar results were evident for a cardiac myosin-II-specific inhibitor mavacamten analog (MYK)-in clinical trials for hypertrophic cardiomyopathy (National Institutes of Health, 2016a [NCT02842242] ). Despite rapid recovery of beating after drug washout ( Figure 1D ), LMNA recovered more slowly (>3 h), indicating slow synthesis.
DNA damage in post-natal development with LMNA deficiencies (Liu et al., 2005) led us to hypothesize acute, embryonic changes in phospho-histone gH2AX, as a primary marker of DNA damage. A rapid decrease in DNA damage was surprising with myosin-II inhibition ( Figure 1C -ii) given the decrease LMNA, but an electrophoretic comet assay confirmed the gH2AX results ( Figure 1D ). It is useful to keep in mind that the heart beats reasonably well with LMNA deficiencies and mutations. Because blebb washout recovers beating while LMNA remains low, we anticipated a large spike in DNA damage shortly after washout right inset) . LMNA and DNA damage eventually reached control levels (in hours), but the spike highlights the disruptive effects of actomyosin stress on genome integrity.
Actomyosin contractility is generally downstream of ECM stiffness (Ulrich et al., 2009; Engler et al., 2006) , including for immature CMs (Engler et al., 2008; Jacot et al., 2008) . Acute perturbations of collagen matrix might therefore be expected to affect DNA damage. Collagenase treatment for 45-min indeed resulted in rapid decreases in DNA damage and LMNA (Figure 1E) , consistent with rapid softening of E4 hearts (50%) and weaker beating (Majkut et al., 2013) . Treatment with tissue transglutaminase (TGM), a cross-linker of ECM that stiffens heart and thereby increases basal tension (>2-fold in 2 h [Majkut et al., 2013] ), increased gH2AX and LMNA (only after 3 h) except when collagenase was subsequently added ( Figure 1E ). LMNA thus decreases quickly or increases slowly in response to changes in ECM stiffness or actomyosin tension, both of which appear to also affect DNA damage. Effects are also generally reversible.
DNA Damage in LMNA-Deficient Hearts Perturbs Cell Cycle and Causes Aberrant Beating Excess DNA damage has been shown to impact the cell cycle in post-natal CMs (Puente et al., 2014) , and so, we next sought (C) (i) Immunoblot densitometry reveals LMNA decreases in 45-min upon myosin-II inhibition, but LMNA recovery takes >3 h upon washout. MS confirms 1-h data with 29 LMNA-specific peptides, and inset shows LMNB1 remains unchanged. (ii) DNA damage gH2AX also decreases but spikes upon blebb washout (5.5 h, light blue). Bar graph of LMNA and gH2AX changes 1 h post washout. Bottom right immunoblot shows MYK treatment for 1.5 h also affects LMNA and gH2AX. One-way ANOVA (Dunnett's test versus DMSO Ctrl avg of 0.5 h, 6 h): *p < 0.05, ** < 0.01; t test (versus plateau average of 2, 3, and 4.5 h time points): #p < 0.05. All error bars indicate ± SEM. (D) Electrophoretic comet assay of DNA damage validates gH2AX quantitation, with g-irradiation control. (E) Immunoblot of hearts treated with collagenase and/or transglutaminase (TGM) (8 hearts per lysate). Matrix digestion rapidly decreases LMNA and gH2AX, consistent with low stress; cross-linking has opposite and reversible effect by 3 h (t test: *p < 0.05; superfluous blot lanes have been removed and indicated by a blank space). (F) (i) Morpholino KD of LMNA (MO LMNA ) does not affect beating versus MO Ctrl , but (ii) MO LMNA increases DNA damage (gH2AX) and cell cycle inhibitor p21 unless rescued by myosin-II inhibition (i and ii). Two immunoblots (anti-LMNA, p21, and b-actin) and display proteins (anti-LMNB1, gH2AX, HSP90) of interest above loading controls. (8 hearts per lysate). One-way ANOVA: *p < 0.05, *** < 0.001. to assess the biological consequences of DNA damage in LMNA-suppressed embryonic hearts. Morpholino (MO) mediated knockdown (KD) of LMNA (MO LMNA ; 40% KD in 24 h) was achieved with no significant effect on contractile beating (Figures 1F-i and S1E). LMNA is thus not primarily upstream of beating, consistent with knockout mice (Singh et al., 2013) . Although past studies also suggest LMNA is not detectable in early embryonic hearts and is therefore dispensable (Solovei et al., 2013; Stewart and Burke, 1987) , morpholino KD increased gH2AX in E4 hearts ( Figure 1F -ii). Similar effects were seen by modest repression with retinoic acid (RA) of LMNA (20% only after 3 days) that acts transcriptionally , while RAantagonist (AGN) upregulated LMNA and suppressed DNA damage ( Figures 1F and 1G) . blebb was sufficient to rescue the DNA damage in MO LMNA KD hearts, supporting our hypothesis that high contractility coupled to low LMNA causes excess damage.
Bona fide DNA damage can perturb cell cycle (Puente et al., 2014) ; the cell cycle inhibitor p21 indeed trended with gH2AX in MO-treated hearts ( Figure 1F -ii). EdU (5-ethynyl-2 0 -deoxyuridine) integration before and after blebbistatin addition and washout (per Figures 1A-1C ) further revealed an increase in cells in G2, with fewer cells in S, and an increase in 4 N cells ( Figure 1G ). Given that acute DNA damage can inhibit cell cycle in developing heart and is somehow coupled to matrix-myosin-lamins ( Figure 1H ), we assessed DNA damage that was directly and abruptly increased with etoposide (4-fold, 1 h) (Figure 2A ). This inhibitor of replication and transcription quickly caused aberrant beating that could be reversed upon drug washout ( Figure 2B ); many cardiac laminopathies exhibit arrhythmias and broader conduction defects (Fatkin et al., 1999) . No such effects were seen with the same dose of H 2 O 2 (for oxidative stress) relative to DMSO control hearts unless H 2 O 2 exposure was sustained for days. DNA damage can have multiple causes, ranging from drugs and oxidative stress to nucleases, but reversal of damage from natural sources or etoposide in hours (Figures 1F, 1G, and 2A) suggest an important role for DNA repair factors ( Figure 2C ).
LMNA KD in Intact Hearts and Human iPS-CMs: Nuclear Rupture and Loss of DNA Repair To address how increased mechanical stress causes DNA damage, the integrity of the nucleus was scrutinized in intact E5 hearts doubly transfected with DNA repair protein GFP-KU80 (XRCC5) and with a cytoplasmic protein that can bind nuclear DNA, mCherry-cGAS (cyclic GMP-AMP synthase [Raab et al., 2016] ) ( Figure 3A-i) . Cytoplasmic mis-localization of KU80 and concomitant formation of cGAS puncta at the nuclear periphery provided evidence of nuclear rupture in transfected hearts (Figure 3A- cells increased with MO LMNA KD unless blebb was added . Myosin-II inhibition disrupted sarcomeres, which rapidly recovered upon drug washout ( Figure 3A -iii), consistent with beating ( Figures 1A-1C) ; and mis-localization of KU80 and cGAS showed the same trends ( Figure 3A -iv), without any apparent changes in cell viability (Figure 2A-i) . DNA damage again spiked upon blebb washout and remained excessively high with addition of a nuclear import inhibitor (Imp-i; ivermectin) that keeps KU80 mis-localized to cytoplasm ( Figures 3B-i Figure 2B ) and express low LMNA relative to some well-studied human cell lines (e.g., lung-derived A549 cells) and relative to mature heart, which is much stiffer than embryos . Cell morphologies and sarcomere striations resemble those of embryonic or fetal CMs. On very stiff gels (40 kPa) but not on gels as soft as embryos (0.3 kPa), hiPS-CMs exhibited cytoplasmic, mis-localized KU80 ( Figure 3D ), consistent with envelope rupture under high nuclear stress ( Figure 1H ). Nuclear blebs typical of ruptured nuclei formed at points of high curvature in such cells , appearing rich in LMNA but depleted of LMNBs ( Figure 3D ). Stress-induced nuclear rupture was also imaged as rapid and stable accumulation of mCherry-cGAS upon nuclear probing with a high curvature atomic force microscopy (AFM) tip (<1 mm), using nanoNewton forces similar to those exerted by a cell's actomyosin ( Figure 2C ).
KD of LMNA (siLMNA) doubled the fraction of cells with cytoplasmic KU80 (Figures 3E-i and S2D-i) and increased gH2AX foci (Figures 3E-ii and S2D-ii). These observations seem consistent with iPS-CM results for LMNA defects, which show nuclear blebbing (Lee et al., 2017) , focal loss of nuclear membrane (Siu et al., 2012) , cytoskeletal defects (Bollen et al., 2017) , and fibrosis, all of which increase with electrical stimulation of contraction. We found LMNA levels in hiPS-CMs exhibited sensitivity to substrate stiffness similar to that in embryonic hearts ( Figure 3E -iii), and we saw blebb-treated siLMNA cells on rigid plastic rescued nuclear rupture ( Figure 3E-i) , as well as DNA damage ( Figure 3E -ii). Relaxation of rigidity-driven actomyosin stress can thus limit nuclear rupture.
Cytoplasmic mis-localization of KU80 is merely representative: repair factors 53BP1 and RPA2 also simultaneously mislocalized to the cytoplasm upon LMNA KD ( Figure 2E-i) . Timelapse images of GFP-53BP1-expressing cells further revealed mis-localization persists for hours ( Figure S2E -ii). However, total KU80 levels did not vary ( Figure 2F ), suggesting that nuclear retention is key.
To assess whether mis-localization of repair factors is a general consequence of increased mechanical stress, LMNA KD of both CM and U2OS osteosarcoma cells was followed by cyclic stretch at a frequency and magnitude similar to that of the intact heart (8% uniaxial strain at 1-Hz frequency) . Mis-localized GFP-KU80 increased >2-fold with imposed stretching of MO LMNA KD E4 CMs but not MO Ctrl , and the fold-increase was even more dramatic with the nonbeating U2OS cells because baseline mis-localization was very low. DNA damage also increased with stretching of MO LMNA CMs while LMNA levels showed an insignificant increase ( Figure 3F-iii ). An acute increase in stress without a proportionate increase in LMNA can thus cause mis-localization of repair factors and DNA damage, which could affect tissue-level function (Figures 2A and 2B ). Etoposide-treated hiPS-CM organoids indeed show aberrant beating ( Figure 2G ).
Loss of Repair Factors or LMNA: DNA Damage, Binucleation, Micronuclei, and Cell-Cycle Arrest To assess the impact of a limited capacity for DNA repair in cells, key individual DNA repair factors were partially depleted individually and in combination (si-Combo). BRCA1 is implicated in myocardial infarction and ischemia (Shukla et al., 2011) , and RPA1 appeared abundant and constant in level in our MS of drug-or enzyme-perturbed hearts ( Figures  1C and 1E ). DNA damage increased in hiPS-CMs for all repair factor KDs, and the combination proved additive (Figure 4A-i) .
Excess DNA damage in post-natal hearts has been associated with CM binucleation (Aix et al., 2016 )-a hallmark of irreversible cell cycle exit. Soft ECM suppressed binucleation of embryonic CMs relative to stiff ECM ( Figure 4A -ii) while suppressing mislocalization of repair factors ( Figure 3E -i). Partial KD of DNA repair factors directly increased the fraction of binucleated hiPS-CMs, as well as those with micronuclei ( Figure 4A -iii), both of which correlated strongly with gH2AX. Repair factor KD further increased the fraction of ''4N'' cells (versus ''2 N''; , in agreement with trends for blebb-treated hearts ( Figure 1G ) and with mitotic arrest. LMNA KD had all of the same effects, consistent with a role in repair factor retention in nuclei, and, consistent also with a late checkpoint, KD showed more DNA damage per DNA in 4 N cells relative to control cells ( Figure 3B ). Importantly, with siLMNA or siCombo KD, increased gH2AX and cell cycle perturbations were evident not only at steady state but also within 1 h of damaging DNA with etoposide (per Figure 2) -which partially recovered after drug washout ( Figure 4B ).
Myosin-II inhibition once again rescued the DNA damage, as well as cell cycle effects, in siLMNA KD cells ( Figure 4C-i) , whereas siCombo cells maintained high DNA damage (Figure 3C) . Furthermore, overexpression of relevant DNA repair factors (with GFP-KU70, KU80, BRCA1 = ''GFP-Combo'') rescued only the excess DNA damage in nuclear-ruptured cells compared to non-ruptured ( Figure 4C -ii). A baseline level of damage in the latter cells was not affected, likely because repair factors become limiting only upon nuclear rupture or depletion. A combination of factors (GFP-Combo) rescued the excess damage, while one repair factor had no effect on its own (53BP1) even on the ruptured nuclei. Rescue of DNA damage again suppressed the fraction of 4 N cells ( Figure 4B lower) and cells in G2 ( Figure 3D ).
Since cardiac telomere attrition has been implicated in CM binucleation (Aix et al., 2016) , as well as in cardiomyopathies and heart failure (Sharifi-Sanjani et al., 2017), we assessed ruptureassociated telomere shortening as a more localized form of DNA damage ( Figure 4D ). U2OS osteosarcoma cells with ruptured nuclei (cytoplasmic anti-KU80) showed lower total intensity of telomeric repeat-binding factor-1 (TRF1, as an mCherry fusion; Figure 4E -i) and smaller TRF1 foci size ( Figure 4E -ii), as well as higher gH2AX in these LMNA KD cells. Importantly, partial KD of either KU80 or multiple repair factors also caused telomere attrition in cells with normal LMNA levels ( Figure 4F ). Proper retention of DNA repair factors within stressed nuclei thus requires sufficient LMNA, but LMNA also interacts with key repair factors (including KU70/80 and RPA1) as confirmed by immunoprecipitation-MS (IP-MS) ( Figure S3E ). IP-MS further indicates KU80 interacts preferentially with non-phosphorylated LMNA (GFP-wild type [WT]) compared to its phospho-solubilized nucleoplasmic form (per IP by anti-pSer22 or phosphomimetic mutant GFP-S22E) ( Figure 4G ), suggesting that LMNA scaffolds the repair of DNA at the periphery-which often includes telomeres ( Figure 4H ). Importantly, analysis of telomeres in embryonic CMs by quantitative FISH (Q-FISH) revealed LMNA KD causes telomere shortening unless actomyosin is inhibited ( Figure 4I ). The findings motivate deeper mechanistic insights into how LMNA adjusts to actomyosin stress ( Figures 1A-1E , 3C, and 3E-iii) to thereby regulate DNA damage and the cell cycle.
LMNA Effectively Stiffens Nuclei during Development and Increases with Collagen-I ECM
To begin to assess in normal beating hearts how LMNA senses stress, nuclear deformations were imaged at E4-just 1 to 2 days after the first heartbeat ( Figure 5A ). Transfection of a minor fraction of CMs in hearts with mCherry-histone-H2B or GFP-LMNA facilitated imaging, and each 1-Hz contraction of heart tissue was seen to strain individual CM nuclei by up to 5%-8%. Recall that 8% stretch at 1-Hz was sufficient to rupture CM nuclei ( Figure 3F ). While transfection did not affect overall tissue-level beating, GFP-LMNA nuclei deformed much less than neighboring control nuclei ( Figure 5A -ii), consistent with in vitro studies showing LMNA stiffens the nucleus (Pajerowski et al., 2007; Lammerding et al., 2006) . MS of lysates quantified 29 unique LMNA peptides at E4 ( Figure 1C ), confirming our early detection of functional LMNA ( Figure 1B ) despite past reports (Solovei et al., 2013; Stewart and Burke, 1987) , showed a rapid increase in LMNA expression by 3-fold from soft E4 hearts to stiffer E10 hearts ( Figures 5B and 5C ). B-type lamins remained relatively constant, in agreement with studies of diverse soft and stiff adult tissues that suggest LMNA-specific mechanosensitivity (Figures 4A-4C) . Trends are confirmed by confocal IF and immunoblots of embryonic heart (Figures 5C-i and 5C-ii, insets; Figure S4D ).
Collagen-I (a-1 and a2) exhibited the largest fold change in MS analyses of heart development ( Figure 5B ), with calibrated spike-ins of purified collagen-I matching past measurements of collagen in developing chick hearts (Woessner et al., 1967) ( Figure 4E ). Collagen-I becomes the most abundant protein in developed animals and is a major determinant of tissue stiffness (Shoulders and Raines, 2009); therefore, its increase together with many other structural proteins ( Figure 4C ) is consistent with heart stiffening ( Figure 2F ) (Majkut et al., 2013) . Mechanosensitive proteins at the interface between adhesions and actomyosin cytoskeleton were also upregulated, including paxillin (Zaidel-Bar et al., 2007) and vinculin (Huang et al., 2017) , consistent with increased adhesion and contractile stress (Geiger et al., 2009 ). Downregulation of protein synthesis and catenins suggest a transition from a rapidly growing, epithelial-like embryo to a more specialized, terminally differentiated state.
Lamin-A:B ratio increased with collagen-I (Figures 5C-i and S4F) and with tissue stiffness E t ( Figure 5 -ii), with a power law exponent a = 0.3 (versus collagen-I) similar to that for diverse tissue proteomes (Cho et al., 2017) . Experiments fit a ''use it or lose it'' mathematical model ( Figure 5C -i) wherein mechanical tension on filamentous collagen-I and LMNA suppresses protease-driven degradation ( Figure 5C -i). The plot versus E t yielded a0.7 that is similar for adult tissues (a0.6 ), with soft E10 brain and stiff E10 liver fitting well (Figures 4F and 4G) . Importantly, 45 min collagenase softened E4 hearts by 50% and decreased LMNA ( Figure 5C ), per Figures 1A-1E.
Different combinations of drugs were used to identify mechanisms for how LMNA levels change in tight coordination with collagen-I and tissue stiffness. MS-derived heatmaps of drugtreated E4 hearts (e.g., collagenase and blebb) reveal rapid and large decreases in collagen-I, vinculin, and LMNA ( Figure 5D ; confirmed by immunoblot, Figure 5A ). Little to no change was observed across most of the detected proteome including DNA repair factors (KU70 and RPA1 [ Figure 5B -i]), matrix-metalloproteinase MMP2 (pro-and cleaved forms; Figures 5B-ii and Figure 5 . Early Embryonic LMNA Increases with Collagen-I and Tissue Stiffness E t (A) (i) E4 heart beating with GFP-LMNA transfection shows nuclear ''beating.'' Right: trace of tissue strain tensor quantified using fiduciary transfected nuclei per (Taber et al., 1994) or nuclear strain from nuclear area and aspect ratio (AR). (ii) Overexpression does not affect local or global tissue strain (left), but GFP-LMNA nuclei deform less than mCherry-H2B nuclei (n > 8 nuclei per cond.; t test: *p < 0.05). All error bars indicate ± SEM. (B) Proteomic heatmap of E4, E6, and E10 hearts (n = 8, 2, and 1 heart(s) per lysate, respectively), ranked by fold change from time-average: collagen-I and LMNA top the list. (C) (i) Lamin-A:B ratio from MS scales with collagen-I and fits ''use it or lose it'' model of tension-inhibited turnover of structural proteins, with stress sensitivity denoted as x. Inset: confocal images of LMNA and B in hearts taken at same settings suggest LMNA increases while LMNB remains constant. (ii) Lamin-A:B scaling versus E t from micropipette aspiration (lower inset), with exponent a similar for adult tissue (a 0.6) . Cyan: softening by collagenase decreases LMNA. Upper immunoblot (norm. to HSP90): LMNB varies by < 20% from E4-E10 as LMNA increases (n > 8 hearts per lysate). (D) MS intensity fold changes relative to DMSO for Trx-i inhibitor of translation (cycloheximide, 1 mM); MMP-i pan-MMP inhibitor (GM6001, 10 mM); CDK-i (RO3306, at >3.5 mM doses to inhibit many CDKs) to suppress LMNA phosphorylation. Cyan boxes indicate rescues (n = 8 hearts per lysate; t test versus DMSO: *p < 0.05, ** < 0.01, *** < 0.001). (E) (i) E4 hearts treated with blebb ± MMP-i's (2 h; n = 6 hearts per lysate). pSer390 bands at intact MW (73 kDa) and 42 kDa, consistent with fragments (Baghirova et al., 2016; Prudova et al., 2010) (C) Well-separated E4 CMs at 24 h on gels. As with tissue (A), isolated CMs spread, elongate, and striate more with stiffness. Blebb on rigid plastic causes rounded or dendritic CM, with loss of striation. MMP inhibitors have no effect.
(legend continued on next page) 5B-iii), cardiac myosin-II (MYH7B), vimentin (VIM), and B-type lamins. Similar results were obtained even in the presence of the translation inhibitor (Trx-i) cycloheximide, except for decreases in a few cytoskeletal proteins that indicate rapid translation (e.g., actin [Katz et al., 2012] ). Decreased translation thus does not explain the heart's decreases in collagen-I and LMNA with blebb and/or collagenase.
To clarify how myosin-II inhibition (intracellular) leads to a rapid decrease in collagen-I (ECM) in intact hearts, a pan-inhibitor of matrix-metalloproteinases (MMP-i) was used with blebb. The combination surprisingly prevented collagen-I degradation. In contrast, a CDK inhibitor (CDK-i; likely affecting CDK4/6) that limits interphase phosphorylation of LMNA (e.g., pSer22 normalized to total LMNA: pSer22/LMNA in Figure 5A ) rescued blebb-induced decreases in LMNA levels without affecting the collagen-I decrease. Vinculin's decrease concurs with decreased actomyosin tension regardless of MMP-i ( Figure 5D ), but MMP-i surprisingly rescued blebb-induced decreases in LMNA similarly to CDK-i ( Figures 5D and S5A ).
Mechano-protection of the Genome Is Limited by LMNA Phospho-solubilization We hypothesized that one or more MMPs directly degrade LMNA. Nuclear MMP2 is well documented for many cell types including CMs (Xie et al., 2017) , and LMNA (but not B-type lamins) has been speculated to be a proteolytic target (Baghirova et al., 2016) . Beating E4 hearts treated with MMP-i or an MMP2-specific inhibitor, MMP2-i, rescued the blebb-induced decrease in LMNA in immunoblots that were also probed with a previously untested anti-pSer390 (Figures 5E-i and 5E-ii). For other phosphosites, interphase phosphorylation, solubilization (Kochin et al., 2014) , and subsequent degradation of LMNA (Naeem et al., 2015; Bertacchini et al., 2013) are already known to be suppressed by actomyosin tension on nuclei Swift et al., 2013) . Intact phospho-LMNA (73 kDa) increased upon blebb treatment (Figure 5E-iii; pSer390 intact / LMNA intact ), but even more dramatic was the suppression by MMP2-i and MMP-i (regardless of blebb) of a 42 kDa pSer390 fragment (pSer390 fragm ./pSer390 intact ) . Fragment size matches predictions for MMP2 digestion (Song et al., 2012) but is likely a transient intermediate that is further degraded (Buxboim et al., 2014) (Figure 5E-v) . MS of hearts treated with blebb or collagenase not only confirmed the trend for the fragment (>6 LMNA peptides) ( Figure 5F ) but also showed MMP2 levels remain constant, as supported by immunoblots for MMP2's activation (cleaved/pro-MMP2 ratio; Figures 5G and S5B). Anti-MMP2 (for both pro-and active forms) was mostly nucleoplasmic in isolated CMs with localization unaffected by actomyosin inhibition ( Figure 5H ). Nucleoplasmic MMP2 in neonatal CMs (Baghirova et al., 2016; Kwan et al., 2004) suggests that, independent of maturation stage, active MMP2 is localized appropriately for degradation of phospho-LMNA downstream of actomyosin tension ( Figure 5E-v) .
DNA damage was assessed after acute 2-h treatments of CDK-i or MMP-i plus blebb. Whereas MMP-i had no effect on gH2AX relative to blebb alone, CDK-i plus blebb greatly suppressed DNA damage ( Figure 5I ). Since CDK-i maintains LMNA at the lamina (unlike MMP-i) and thereby stiffens and stabilizes the nucleus (per Figure 5A and single-cell measurements ), the results suggest that even low levels of nuclear stress are resisted to minimize both rupture and DNA damage in the embryonic heart.
Isolated CMs Elucidate Effects of ECM Elasticity and Contractility on LMNA Turnover by MMP2
Intact heart presents many complications to understanding LMNA regulation and its function. As the heart stiffens in development, for example, collagen ligand also increases greatly for adhesion ( Figures 5B and 5C ), sarcomere assembly becomes very dense , cells and nuclei elongate (Figures 6A -ii and S6B) with stabilization by microtubules (Robison et al., 2016) , cells align ( Figure 6C ), and nuclear volumes decrease ( Figure 6D ). Gels with constant collagen-I ligand and of controlled stiffness (0.3-40 kPa) ( Figure 6B ) showed-after just 24 h-the same stiffness-correlated morphology and cytoskeleton trends for isolated E4 CMs as the intact heart from E4 to E11 ( Figure 6C ). Although matrix elasticity had large effects on size, shape, sarcomere assembly, and contractility of early CMs ( Figures 6A-i, 6A -ii, and S6E) similar to later stage CMs (Ribeiro et al., 2015; Engler et al., 2008; Jacot et al., 2008) , blebb quickly disrupted cell spreading, striation, and elongation on stiff gels (10 kPa) and on collagen-coated rigid plastic ( Figure 6C ). Gels that mimic the stiffness of E4 heart (1-2 kPa) were optimal for cell beating ( Figure 6F ), consistent with past studies (Majkut et al., 2013; Engler et al., 2008) , and nuclear ''beating strain'' in isolated CMs (Figures 6F-i and S6G-i) was similar in magnitude to that in intact heart (5%-8%) ( Figure 5A) . Surprisingly, lamin-A:B intensity increased monotonically with gel stiffness rather than exhibiting an optimum (Figures 6D-i and S6G-ii). LMNA's increase depended on myosin-II, as did cell/nuclear aspect ratio (AR), spreading, and sarcomere assembly ( Figures 6C, 6D -ii, and S6A,E). Monotonic increases with stiffness of ECM agree with elevated isometric tension as documented for other cell types (e.g., Engler et al., 2006) . Remarkably, MMP-i or MMP2-i rescued the blebb-induced decrease in lamin-A:B at the sin-glecell level ( Figure 6D-i) as seen for intact embryonic hearts ( Figure  5D -i) despite no significant effects on cell morphology or striation ( Figures 6C and 6D -ii).
(D) (i) Lamin-A:B increases with gel stiffness except with blebb (n > 50 cells per grp). Effects are rescued by MMP-i's on rigid plastic. (ii) Cell and nuclear AR (inset) increase as CMs polarize on stiffer gels. Blebb reduces cell/nuclear AR, but MMP-i shows no affect (n > 47 cells per cond.; all error bars indicate ± SEM). (E) (i) LMNA is more nucleoplasmic in CMs on soft gels (0.3 kPa) than stiff (40 kPa). Blebb gives higher nucleoplasmic signal. (ii) Histograms of phosphorylation (pSer/LMNA) for pSer22 and pSer390. Signals for both sites are higher for soft gels and stiff gels + blebb. pSer/LMNA for rare mitotic CMs (yellow) are typically 10-to 20-fold higher than interphase CMs (cyan arrows). (iii) pSer/LMNA ratios for pSer22 and 390 (n > 11 nuclei per cond.). (F) (i) Phospho-mimetic mutant GFP-S22E (± Trx-i, 3 h) probed with anti-LMNA shows low LMNA versus GFP-S22A cells. Stable lines were made within a stable shLMNA line to minimize both endogenous LMNA and overexpression artifacts. Low-MW fragments (green arrows) are not detected in GFP-S22A cells.
(ii and iii) Basal DNA damage and (iv) % 4 N cells are highest in GFP-S22E cells, but blebb minimizes differences (n > 93 nuclei per cond.; t test *p < 0.05, ** < 0.01, *** < 0.001; irrelevant blot lanes have been removed and is indicated by a blank space).
Since myosin-II-dependent increases in lamin-A:B versus gel stiffness for isolated CMs ( Figure 6D -i) align with lamin-A:B's increase with heart stiffness and contractility during development ( Figures 5B and 5C ), LMNA phosphorylation was re-examined (per Figures 5D and S5A) . IF with anti-pSer22 and pSer390 proved consistent with tension-suppressed LMNA phosphorylation and turnover: cells on soft gels showed high nucleoplasmic phospho-signal as did cells on stiff gels treated with blebb ( Figure 6E ). The latter also showed cytoplasmic phosphosignal, consistent with multisite phosphorylation in interphase (Kochin et al., 2014) . Regardless, LMNA was similarly low and decreased at the nuclear envelope ( Figure 6E-i) . Phospho-signal normalized to total LMNA (pSer per LMNA) was also 2-to 3-fold higher in CMs on soft gels than in stiff gels . blebb-treated cells on stiff gels again showed increased pSer/LMNA for both phospho-sites. Signal in interphase cells was, however, >10-fold lower than in rare mitotic CMs (Figure 6E -ii, inset: purple arrow). Studies of stable phosphomimetic mutants (GFP-S22A and GFP-S22E) conformed to the model, with higher nucleoplasmic signal but lower overall levels for S22E (Figures 6F-i and S7A). Inhibition of translation for 3 h (Trx-i) showed more degradation only for S22E (Figures 6F-i and S7B), and MMP2-i treatment increased S22E intensity (Figure 7C ) consistent with inhibition of phospho-LMNA turnover. S22E-phosphomimetic cells also exhibited higher DNA damage (Figures 6F-ii and 6F-iii) and more cells in late cell cycle (4 N; Figure 6F-iv) that were more suppressed by acute blebb than S22A cells. Reduction of nuclear stress by soft matrix or actomyosin inhibition at the single-cell level thus favors LMNA interphase phosphorylation, nucleoplasmic solubilization, and subsequent degradation-while also suppressing DNA damage and cellcycle arrest.
DISCUSSION
LMNA defects cause disease through ''cell-extrinsic mechanisms'' that likely include ECM and/or cytoskeletal stress. Mosaic mice in which 50% of the cells express defective LMNA maintain a normal lifespan, whereas mice with 100% defective cells die within weeks of birth (de La Rosa et al., 2013) . Cultures on rigid plastic of the same cells (and similar cell types [Hernandez et al., 2010] ) exhibit premature senescence and apoptosis, as is common with excess DNA damage, but growth and viability are surprisingly rescued upon culture on almost any type of ECM. Soft matrix certainly reduces cytoskeletal stress and suppresses nuclear rupture and DNA damage in CMs with low LMNA ( Figure 3E ). The findings are further consistent with the observation that laminopathies spare soft tissues such as brain, independent of lineage or developmental origin, but generally affect stiff and mechanically stressed adult tissues including muscle or bone (Cho et al., 2018) .
Early embryos are soft, with minimal ECM, but as tissues form and sustain higher physical stresses, collagen-I accumulates, and stiffening of the developing tissue minimizes the strain on resident cells. However, increasing stiffness and stress necessitate an adaptive mechanism to protect against nuclear stress, and accumulation of mechanosensitive LMNA fulfills this roleunless actomyosin stress is inhibited (Figures 1A-1C) . LMNA thus mechano-protects DNA by retaining repair factors in the nucleus ( Figures 3A-3D ), which thereby prevents excessive DNA damage in stiff microenvironments and/or under high actomyosin stress ( Figure 7A ). Rapid change in LMNA protein independent of any transcription or translation (Trx-i) rules out many possible contributing pathways to the equally rapid DNA damage response. Such conclusions about causality are otherwise difficult to achieve with experiments conducted over many hours or days such as with mouse models. Results with the cardiac myosin-II specific inhibitor (MYK) in clinical trials for some cardiomyopathies (National Institutes of Health, 2016a [NCT02842242]) further suggest an unconventional method to attenuate DNA damage in the heart (Figures 1C and 1D) .
Loss of DNA repair factors could compromise genome integrity, but enhanced entry of cytoplasmic nucleases (Maciejowski et al., 2015) would seem unlikely to generate gH2AX foci distributed throughout the nucleoplasm ( Figures 3E-ii, 4A-i) . Indeed, cytoplasmic proteins that bind DNA strongly (e.g., cGAS) are restricted to rupture sites. Rupture results in ''global'' mis-localization of multiple DNA repair factors in several pathways ( Figure S2E-i) Irianto et al., 2017) , and repair factor depletion causes excess DNA damage before, during, and after transiently induced damage (by 1 h etoposide; Figure 4B ).
Remarkably, MMPs that degrade and remodel collagen-I matrix within hours or less are found here to directly regulate LMNA of the ''nuclear matrix'' ( Figures 5D-i, 6C, and 6D ), which indicates a surprising inside-outside symmetry (Figure 7) to the ''use it or lose it'' mechanism ( Figures 5C and 7B ) of stress-stabilizing fibers. While both phospho-LMNA and MMP2 are found mostly in the nucleoplasm of CMs, the specific functions of MMP2 in the nucleus, the location of LMNA degradation, and its activation and localization mechanisms remain to be elucidated. Nuclear MMPs are not new (Xie et al., 2017) , but tension regulation of their substrates has not been described. Our studies of isolated CMs on soft or stiff gels further demon-strate steady-state LMNA levels are determined primarily by a basal tone related to average morphologies of cells and nuclei, as opposed to dynamic contractions that intermittently strain the nucleus ( Figures 3F, 6D , and S6G). Basal and dynamic strain might contribute to a ''tension-time integral'' model that seems predictive for hypertrophic versus dilated cardiomyopathy disease fates (Davis et al., 2016) . Roles for MMPs in such diseases and compensatory changes in LMNA could emerge.
Reasons why cells do not simply maintain high LMNA levels at all times in all tissues could be physical as well as biochemical. An overly rigid nucleus might disrupt cytoskeletal assembly and function. Also, LMNA fine tunes differentiation and matura-tion by regulating many cytoskeletal genes via the MKL1/SRF pathway and by interacting with regulatory factors at the nuclear periphery. Nonetheless, accumulation of LMNA in stiff tissues of the embryo begins earlier than reported (Stewart and Burke, 1987) and tracks nonlinearly what eventually becomes the most abundant protein in adult animals, collagen-I ( Figure 5C ). Collagenase softens tissue and decreases LMNA consistent with scaling trends, and the scaling LMNA collagen-I 0.3 in embryos matches meta-analyses of all available transcriptomes analyzed for diverse normal and diseased adult and developing from Swift et al., 2013; Rö ber et al., 1989) . Mechano-coupled accumulation of LMNA and collagens that begin in early development could thus persist well into maturation and perhaps even to disease and aging of adult tissues ( Figure 7G ). Thus, mechano-protection of the genome by LMNA likely plays a critical role not only in embryonic development but also in a broad range of adult diseases. , with (ii) governing equations. Squares, genes; circles, protein. LMNA and myosin-II protein (l and m) are weak regulators of the Serum Response Factor (SRF) pathway. LMNA upregulates its own transcription (via RARg). LMNA and collagen-I protein turnover with x and z sensitivity of degradation to myosin tension. Myosin-II protein turnover depends on matrix elasticity E, which scales with collagen-I ( Figure 4E ).
hearts across species (Cho et al., 2017) (Fig. S7D) . The scaling is consistent with that across proteomes of diverse chick embryo tissues at E18 (Fig. S7E) , as well as adult mouse tissues (a = 0.4) 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead Contact, Dennis E. Discher (discher@seas.upenn.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Embryonic Chick Hearts and Cardiomyocytes
White Leghorn chicken eggs (Charles River Laboratories; specific pathogen free (SPF) Fertilized eggs, Premium #10100326) were used to extract embryonic hearts. SPF chicken eggs from Charles River are produced using filtered-air positive-pressure (FAPP) poultry housing and careful selection of layer flocks. Every flock's SPF status is validated in compliance with USDA memorandum 800.65 and European Pharmacopoeia 5.2.2 guidelines. SPF eggs were incubated at 37 C with 5% CO 2 and rotated once per day until the desired developmental stage (e.g. four days for E4; Hamburger-Hamilton stage 23-24 (HH23-24) ). Embryos were extracted at room temperature (RT) by windowing eggs, carefully removing extraembryonic membranes with sterile sonicated forceps, and cutting major blood vessels to the embryonic disk tissue to free the embryo. The extracted embryo was then placed in a dish containing PBS on a 37 C-heated plate, and quickly decapitated. For early E2-E5 embryos, whole heart tubes were extracted by severing the conotruncus and sino venosus. For more mature (>E5) embryos, embryonic disks were extracted by windowing the egg, cutting out the embryo with the overlying vitelline membrane intact, lifting out the embryo adherent to the vitelline membrane and placing in a dish of prewarmed PBS. Extraembryonic tissue was carefully cut away using dissection scissors and the embryo was teased away from the vitelline membrane using forceps. Whole hearts (>E5) were extracted by severing the aortic and pulmonary vessels. The pericardium was carefully sliced and teased away from the ventricle using extrafine forceps. E10 brain and liver tissue were collected from the presumptive midbrain and hepatic diverticulum, respectively. All tissues were incubated at 37 C in prewarmed chick heart media (a-MEM supplemented with 10 % FBS and 1% Penn-strep, Gibco, #12571) for at least 1 hrs for stabilization, until ready for use.
To isolate primary embryonic CMs from tissue, whole hearts were diced to submillimeter size and digested with trypsin/EDTA (Gibco, #25200-072). Approximately 1 ml of trypsin per E4 heart was added and incubated for 13 min at 37 C with gentle shaking, then placed upright for 2 min to let large pieces of tissue settle to the bottom of the dish. The supernatant was carefully removed and replaced with an equal volume of fresh trypsin for a second round of 15-min incubation at 37 C. Digestion was blocked by adding an equal volume (1:1) of chick heart media. Isolated cells were plated onto collagen-I-coated polyacrylamide (PA) gels and were allowed to adhere for >4 hrs. Spontaneously beating CMs were imaged using an Olympus I81 microscope with a 403 air objective configured for phase-contrast after 24 hrs in culture. As with intact embryonic hearts, cell area and AR were measured with time to quantify beating. All experiments were performed in accordance with the guidelines of the IACUC of University of Pennsylvania.
Induced Pluripotent Stem Cell-Derived Cardiomyocytes (iPS-CMs)
Normal human iPS cells (obtained from Dr. Joseph Wu, Stanford Cardiovascular Institute (CVI) biobank) were cultured following the protocol provided: Matrigel (BD Matrigel, hESC qualified: #354277) was suspended in cold 4 C DMEM/F12 medium 1:200 dilution (DMEM/F12 medium #10-092-CM-Fisher), mixed gently, and 1 ml of this suspension was added to one 6-well plate (Corning Catalog #353046) and incubated for 1 hr at RT to allow Matrigel to coat the surface. The solution was gently aspirated and small aggregates of human iPS cells were added to each well in mTesr1 medium containing 10 mM of ROCK inhibitor (Y27632, 2HCl -50 mg: #50-863-7-Fisher). Culture medium was replaced daily (no ROCK inhibitor) until the cells reached 85% confluency.
Human induced pluripotent stem cells (hiPSCs) were differentiated into cardiomyocytes (hiPS-CMs) using the ''Cardiomyocytes differentiation and maintenance kit'' from Stem Cell Technologies (#05010 & #05020). The differentiation process was followed as described by the manufacturer's protocol. Briefly, the mTesr1 medium with ROCK inhibitor (10 mM) was replaced with differentiation medium A, cultured for 2 days (Day 0), then subsequently to medium B for 2 days (Day 2) and again switched to medium C twice (Day 4 & 6) . From Day 8 onwards, maintenance medium (Day 8) was added/refreshed every 2 days until spontaneous CM beating was observed through imaging.
Cell Lines A549 (human lung adenocarcinoma) cell lines were obtained from ATCC (American Type Culture Collection, Manassas, VA, USA) and U2OS cell lines were obtained from the laboratory of Roger Greenberg, University of Pennsylvania. ATCC provides cell line authentication test recommendations per Tech Bulletin number 8 (TB-0111-00-02; 2010). These include: microscopy-based cell morphology check, growth curve analysis, and mycoplasma detection (by DNA staining) which were conducted on all cell lines used in these studies. All cell lines maintained the expected morphology and standard growth rates with no mycoplasma detected. U2OS and A549 cell lines were cultured in DMEM high-glucose media and Ham's F-12 nutrient mixture (Gibco, Life Technologies), respectively, supplemented with 10% fetal bovine serum (FBS) and 1% penicillin and streptomycin (SigmaAldrich).
METHOD DETAILS Mass Spectrometry (LC-MS/MS) of Whole Heart Lysates
Mass spectrometry (LC-MS/MS, or 'MS') samples were prepared using procedures outlined in Swift et al.. Briefly, 1 mm 3 gel sections were carefully excised from SDS-PAGE gels and were washed in 50% 0.2-M ammonium bicarbonate (AB), 50% acetonitrile (ACN) solution for 30 min at 37 C. The washed slices were lyophilized for >15 min, incubated with a reducing agent (20 mM TCEP in 25-mM AB solution), and alkylated (40 mM iodoacetamide (IAM) in 25-mM AB solution). The gel sections were lyophilized again before in-gel trypsinization (20 mg/mL sequencing grade modified trypsin, Promega) overnight at 37 C with gentle shaking. The resulting tryptic peptides were extracted by adding 50% digest dilution buffer (60-mM AB solution with 3% formic acid) and injected into a high-pressure liquid chromatography (HPLC) system coupled to a hybrid LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific) via a nanoelectrospray ion source.
Raw data from each MS sample was processed using MaxQuant (version 1.5.3.8, Max Planck Institute of Biochemistry). MaxQuant's built-in Label-Free Quantification (LFQ) algorithm was employed with full tryptic digestion and up to 2 missed cleavage sites. Peptides were searched against a FASTA database compiled from UniRef100 Gallus gallus (chicken; downloaded from UniProt), plus contaminants and a reverse decoy database. The software's decoy search mode was set as 'revert' and a MS/MS tolerance limit of 20 ppm was used, along with a false discovery rate (FDR) of 1%. The minimum number of amino acid residues per tryptic peptide was set to 7, and MaxQuant's 'match between runs' feature was used for transfer of peak identifications across samples. All other parameters were run under default settings. The output tables from MaxQuant were fed into its bioinformatics suite, Perseus (version 1.5.2.4), for protein annotation and sorting.
Immunoblotting
Hearts isolated from chick embryos (E4, E6, and E10; n R 8, 4, and 2 per sample, respectively) were rinsed with prewarmed PBS, excised into submillimeter pieces, quickly suspended in ice-cold 13 NuPage LDS buffer (Invitrogen; diluted 1:4 in 13 RIPA buffer, plus 1% protease inhibitor cocktail, 1% b-mercaptoethanol), and lysed by probe-sonication on ice (10 3 3 s pulses, intermediate power setting). Samples were then heated to 80 C for 10 min and centrifuged at maximum speed for 30 min at 4 C. SDS-PAGE gels were loaded with 5 -15 mL of lysate per lane (NuPage 4%-12% bis-Tris; Invitrogen). Lysates were diluted with additional 13 NuPage LDS buffer if necessary. Gel electrophoresis was run for 10 min at 100 V and 1 hrs at 160 V. Separated samples were then transferred to a polyvinylidene fluoride membrane using an iBlot Gel Transfer Device (Invitrogen). The membrane was blocked with 5% nonfat dry milk in TTBS buffer (Tris-buffered saline, BioRad; with 0.1% Tween-20), washed 33 in TTBS, and incubated with primary antibodies against: LMNA (1:500, CST, #4777), gH2AX (1:1000, EMD Millipore, #05-636), HSP90 (1:1000, Abcam, #ab13495), b-actin (1:200, Santa Cruz, #sc-47778), LMNB (1:200, Santa Cruz, #sc-6217), LMNB1 (1:1000, Abcam, ab16048), LMNA pSer22 (1:500, CST, #2026), and/or LMNA pSer390 (1:500, EMD Millipore, custom-made Ab) diluted in TBS to final concentrations generally on the order of 1 mg/ml at 4 C overnight. After washing 33 with TTBS, the membrane was incubated with 1:2000 diluted secondary Ab: anti-mouse HRP-conjugated IgG (GE Healthcare, Little Chalfont, UK), at RT for R1.5 hrs. The membrane was washed 33 again with TTBS and developed with ChromoSensor (GenScript) for 3 min at RT. Immunoblot images were obtained using a HP Scanjet 4850. Densitometry was performed using ImageJ (NIH).
Ex Vivo Drug Perturbations of Embryonic Hearts
For actomyosin perturbation experiments, intact E4 hearts were incubated in 25 mM blebbistatin (EMD Millipore, #203390, stock solution 50 mg/ml in DMSO), 1 mM omecamtiv mecarbil (OM, cytokinetics), or 0.3 -1 mM MYK-581 (gift from MyoKardia, analog of MYK-461 (Green et al., 2016) ) in heart medium at 37 C, for the desired duration. Drug solutions were kept away from light to minimize photodeactivation. Treated hearts were compared to a control sample treated with an equal concentration of vehicle solvent DMSO in heart culture media. Drug solutions were gently washed-out with prewarmed chick heart media 33 for recovery experiments. For collagen matrix perturbations, E4 heart tissue was incubated in 0.3 -1-mg/ml concentrations of collagenase (Sigma, #C7657) for 45 min, or 20-mg/mL transglutaminase (Sigma, T5398) for up to 3 hrs at 37 C. Enzyme activity was blocked by replacing with chick heart media containing 5% BSA. Nuclear import/export of KU80 was inhibited using 5 mM ivermectin (Sigma I8898), 10 mM mifepristone (Sigma M8046), or45 nM leptomycin B (Sigma L2913) for 24 hrs. For transcriptional modulation of LMNA, hearts were incubated with 1 mM retinoic acid (RA, Fisher Scientific) or antagonist to retinoic acid (AGN-193109, Santa Cruz), for short (3 hrs) or long (72 hrs) treatment times. For MMP inhibition during blebbistatin treatment, hearts were incubated with 10 mM GM6001 ('MMP-i', EMD Millipore, #CC1010) or with 30 mM of ARP-100 ('MMP2-i',Santa Cruz, CAS 704888-90-4). 1 mM cycloheximide ('Trx-I', Sigma, C7698-1G) was added to block protein synthesis during actomyosin and/or matrix perturbations. 5 mM ivermectin (Sigma, I8898) was used to inhibit nuclear import. A minimum of 8 hearts were treated and pooled per lysate/experimental condition.
Morpholino Knockdown in Intact Hearts
Vivo-Morpholinos (MO) against LMNA mRNA and the corresponding 5 0 -mispair control were designed according to the manufacturer's guidelines (Gene Tools, Inc.): 5 0 -TTGGCATTCCTGCAACGCCGC-3 0 (MO LMNA ) and 5 0 -TTCGCATTGCTGGAACGGCCC-3 0 (MO Ctrl ). Desired concentrations (1, 2, 5, 10, 30 mM) were prepared by dilution in heart growth medium at 37 C, and the resulting solutions were added to E4 hearts for 24 hrs before analysis.
Alkaline Comet Assay
Alkaline comet assays was performed according to manufacturer's protocol (Cell Biolabs). Briefly, cells were trypsinized, mixed with liquefied agarose at 37 C, placed drop-wise onto the supplied glass slide, and incubated for 15 min at 4 C for the agarose to gel. Lysis buffer from the kit was then added to the solidified gel and incubated for 45 min, followed by an additional 30-min incubation with alkaline solution. Electrophoresis was performed at 300 mA for 30 min followed by a 70% ethanol wash, before samples were air dried overnight. Finally, DNA dye in the kit was added to each sample for 15 minutes, followed by epifluorescence imaging as described above.
Immunofluorescence Imaging Cells were rinsed with prewarmed PBS, fixed with 4% paraformaldehyde (PFA, Fisher) for 15 min, washed 33 with PBS and permeabilized with 0.5% Triton-X (Fisher) in PBS for 10 min. Permeabilized cells were then blocked with 5% BSA in PBS for R1.5 hrs. Samples were incubated overnight with primary antibodies in 0.5% BSA solution, with gentle agitation at 4 C. The primary antibodies used were: LMNA (1:500, CST, #4777), LMNB (1:500, Santa Cruz, #sc-6217), LMNA pSer22 (1:500, CST, #2026), LMNA pSer390 (1:500, EMD Millipore, new custom-made Ab), a-actinin-2 (1:500, Abcam, #ab9465), gH2AX (EMD Millipore, #05-636), KU80 (1:500, Cell Signaling), 53BP1 (1:300, Novus, #NB100-304), RPA2 (1:500, Abcam). Samples were washed 33 in 0.1% BSA in PBS and incubated with the corresponding secondary antibodies at 1:500 dilution for 1.5 hrs at RT (Alexa Fluor 488, 546 and 647 nm; Invitrogen). Cells on gels or glass coverslips were mounted with mounting media (Invitrogen ProLong Gold Antifade Reagent). Images of adherent cells were taken with an Olympus IX81. All images in a given experiment were taken under the same imaging conditions and were analyzed using ImageJ (NIH).
For confocal imaging of embryonic heart tissue, heart samples were rinsed with PBS, fixed with 4% paraformaldehyde (PFA, Fisher) for 45 min, washed 33 with PBS, and permeabilized with 0.5% Triton-X (Fisher) in PBS for 3 hrs. Samples were then incubated overnight with primary antibodies in 0.5% BSA solution with gentle agitation at 4 C (as described above), and washed 33 in 0.1% BSA and 0.05% Triton-X in PBS. Corresponding secondary antibodies were added at 1:500 dilution for 1.5 hrs at RT. Immunostained hearts were then mounted between glass coverslips with mounting media (Invitrogen ProLong Gold Antifade Reagent). Images were taken with Leica TCS SP8 system with either a 633/1.4 NA oil-immersion or 403/1.2 NA water-immersion objective.
siRNA Knockdown and GFP-Repair Factor Rescue All siRNAs used in this study were purchased from Dharmacon (ON-TARGETplus SmartPool; siBRCA1, L-003461-00; siBRCA2, L-003462-00; siKu80, L-010491-00; siRPA1, L-015749-01; siLMNA, L-004978-00 and nontargeting siRNA, D-001810-10). GFP-KU70 and GFP-KU80 were gifts from Dr. Stuart L Rulten from University of Sussex, Brighton, UK, and GFP-53BP1 was a gift from Dr. Roger Greenberg from University of Pennsylvania. Cells were plated 24 hours before transfection. Lipofectamine/nucleicacid complexes were prepared according to the manufacturer's instructions (Lipofectamine 2000, Invitrogen), by mixing siRNA (25 nM) or GFPs (0.2-0.5 ng/ml) with 1 mg/ml Lipofectamine 2000. Final solutions were added to cells and incubated for 3 days (for siRNAs) or 24 hours (for GFPs) in corresponding media containing 10% FBS. mCherry D450A FOK1 TRF1 Expression Death domain (DD)-estrogen receptor (ER)-mCherry-TRF1-FokI constructs were cloned and concentrated TRF1-FokI lentivirus with Polybrene (8 mg/ml) diluted in media was added to U2OS cells at a minimum titer. Doxycycline-inducible TRF1-FokI lines were generated using the Tet-On 3G system. Doxycycline was used at a concentration of 40 ng/ml for 16-24 hrs to induce expression of TRF1-D450A FokI. Shield-1 (Cheminpharma LLC) and 4-hydroxytamoxifen (4-OHT) (Sigma) were both used at a concentration of 1 mM for 2 hrs, to allow for TRF1-D450A FokI stabilization and translocation into the nucleus.
Quantitative Fluorescence In Situ Hybridization and Telomere Analysis
Isolated cells were attached on slides, fixed and stained for PNA telomeric probe as we previously described in (Tichy et al., 2017) . Images of mMuSCs were taken using a Nikon eclipse 90i wide-field epifluorescence microscope equipped with a Prior Proscan III motorized stage, a Photometrics Coolsnap HQ2 14-bit digital camera, and a Nikon 1003/1.40 Plan Apo VC objective. Telomeres were analyzed with the investigators blinded to genotypes and/or conditions using open-source software Telometer, as previously described. The program generates statistics on the entire region of the nucleus. Analysis includes the intensity sum of all Cy5 telomere pixels for a given nucleus (proportional to the cell's total telomere length) and the intensity sum of all DAPI pixels for the nucleus (proportional to total cellular nuclear DNA content).
QUANTIFICATION AND STATISTICAL ANALYSIS Quantification of Beating Strain
Transfected E4 chick hearts were video-imaged using an Olympus I81 at 43 magnification, with a CCD camera. Procedures described by Taber et al. (Taber et al., 1994) were followed to calculate 2D tissue beating strain. Briefly, R3 groups of 3 cells located within 20 mm of each other were selected as fiduciary markers along the outer walls of ventricular tissue. A custom MATLAB program was written to track their displacements and compute trace of the tissue strain tensor (Taber et al., 1994) . Alternatively, for higherthroughput quantitation of contractility changes (n>10 hearts per sample, e.g. following blebbistatin treatment), morphological measurements (projected 2D area, aspect ratio (AR), circularity, perimeter, etc.) of beating whole-hearts were traced with time. Morphology measurements were normalized to baseline reference values, and peak-to-valley 'amplitudes' were averaged over >5 beats to quantify tissue beating strain (e.g. DAR/AR ref ). A similar approach was taken to quantify nuclear deformations: the projected 2D area and aspect ratio (AR) of transfected nuclei (e.g. expressing GFP-LMNA) were traced with time, and the normalized amplitudes were measured and compared across experimental conditions.
Statistics
All statistical analyses were performed and graphs were generated using GraphPad Prism 5. All error bars reflect ± SEM. Unless stated otherwise, all comparisons for groups of three or more were analyzed by one-way ANOVA followed by a Dunnett's multiple comparison test. Pairwise sample comparisons were performed using Student's t-test. Population distribution analyses were performed using the Kolmogorov-Smirnov test, with a = 0.05. Information regarding statistical analyses are included in the figure legends. For all figures, the p-values for statistical tests are as follows: n.s. = not significant, *p<0.05, **<0.01, ***<0.001 (or #p<0.05, ##<0.01 for multiple tests within the same dataset). (A) LMNA MS intensity scales with heart tissue stiffness with exponent α ~ 0.75 similar to that for adult tissue proteomes . All error bars indicate ±SEM. (E) MS measurements of collagen-I calibrated with spike-ins of known amounts of purified collagen-I.
Dividing calibrated measurements by reported myocardium volumes (Kim, et al., 2011) gives collagen-I densities far lower than those used in studies of collagen-I gels (Yang, et al., 2009) , suggesting lower densities are needed for a stiffness in the kPa range as measured for heart ( Fig.4C -ii).
(F) Heart stiffness measurements by micropipette aspiration plotted against collagen-I MS intensity yield power-law scaling comparable to that found for diverse adult tissues . and cells elongate (increased aspect ratio, AR), as the embryonic heart stiffens and cells undergo hypertrophic growth and spreading from E4 -E10. Isolated E4 CMs cultured on gels likewise exhibit increased cell spreading and elongation on stiffer gels (t-test *p<0.05, **<0.01, ***<0.001). All error bars indicate ±SEM.
(B) Two of the most abundantly expressed α-and β-tubulin isoforms (TUBA1C, TUBB7) increase in level from E4 to E10 and the increase is accompanied by a decrease in TTLL12, which tyrosinates and destabilizes microtubules (Robison, et al., 2016) . Trends are consistent with increased stiffness as well as with polarization/elongation of CMs during development (Fig.4D-ii, Fig.S6A ).
(C) Axial alignment of cells (anisotropy, quantified as 1/COV of the major axes of nuclei) increases from early (E4) to late (E11) hearts. Upper left inset: major axis angle distribution of E4 and E11 nuclei.
(D) Nuclear volume (estimated by confocal Z-stack) decreases in development from E4 to E10.
(E) Varying matrix stiffness alone in E4 CM cultures is sufficient to recapitulate trends in morphology and intracellular organization seen in vivo (from E4 to E11).
(F) Normalized cell and nuclear beating strains measured by (i) 'ΔAR/ARref' and (ii) 'ΔArea/Arearef', and (iii) %-beating cells all exhibit an optimum on gels mimicking the stiffness of embryonic hearts (~2 kPa).
Blebbistatin treatment abolishes mechano-sensitivity. (n>10 cells/nuclei per condition).
(G) (i) Nuclear beating strain ('Nucleus ΔAR/ARref') correlates well with cell beating strain ('Cell ΔAR/ARref'), (E) Proteomics dataset for diverse E18 chick embryonic tissues, adapted from Uebbing et al. (Uebbing et al., 2015) . Lmna again increases with Col1a1&2, with exponent αLmna ~ 0.3. Right inset: datapoints for heart samples plotted separately reveal similar scaling.
(F) Tissue-dependent timing of initial LMNA expression in early embryos correlates well with the stiffness that a given tissue eventually achieves in adult (adapted from Rober, et al., 1989) ).
Figure S1 The stiffness of the ECM changes during development. Simultaneous increases in LMNA in the nuclear lamina, due to changes in expression and turnover, stiffen the nucleus and prevent nuclear rupture. Endogenous CDK inhibitors are strongly reduced in heart disease, leading to higher CDK activity, removal of LMNA from the nuclear lamina, and its degradation in the nucleoplasm by MMP2. The softer nucleus is unable to resist the contractile forces, leading to nuclear rupture and loss of DNA repair factors, which are otherwise associated with LMNA.
